Institut du Cancer de Montpellier - Val d'Aurelle (ICM) — Montpellier

Public research footprint of Institut du Cancer de Montpellier - Val d'Aurelle (ICM), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Cancer · Metastatic Colorectal Cancer · Advanced Solid Tumors · Bone Metastatic Castration-resistant Prostate Cancer

Recently updated registry entries

NCT05587296 — A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to… (Active Not Recruiting)
NCT04464226 — Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in… (Active Not Recruiting)
NCT06760819 — A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Institut du Cancer de Montpellier - Val d'Aurelle (ICM)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.